Nervgen Pharma NGEN Income Statement (2024-2026)

NASDAQ NGEN
$1.76 +0.01 (+0.57%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2024 Mar2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 67.32M70.67M72.33M79.90M
Operating items
Research & Development (Quarter) 2.19M3.55M
Selling, General & Administrative (Quarter) 2.01M1.95M
Operating Expenses (Quarter) 4.21M5.49M
Non-operating items
Interest & Investment Income (Quarter) 0.08M-0.08M
Other Non Operating Income (Quarter) 0.01M-0.02M
Net income details
Profit After Tax (Quarter) 2.75M-1.22M
Net Income towards Common Stockholders (Quarter) -2.75M-1.22M
Additional items
EPS (Basic) (Quarter) -0.04-0.02
EPS (Diluted) (Quarter) -0.04-0.02
Shares Outstanding (Quarter) 67.32M70.67M72.33M79.90M
Shares Outstanding (Diluted) (Quarter) 67.32M67.32M72.33M72.33M